List of works - Angus G Jones

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

scientific article published on 17 November 2015

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

scientific article published on 23 October 2018

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin

scientific article

Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studies

scientific article published on 01 May 2021

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature

scientific article

Comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials"

scientific article published on 17 April 2018

Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive.

scientific article published in February 2017

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years

scientific article published on 26 September 2019

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data

scientific article published on 29 April 2019

Effect of the Holiday Season in Patients With Diabetes: Glycemia and Lipids Increase Postholiday, but the Effect Is Small and Transient

scientific article published on 01 January 2014

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.

scientific article

Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes

scientific article published on 07 July 2020

Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine

scientific article

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

scientific article published on 04 August 2015

Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?

scientific article published on 27 June 2019

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

scientific article published on 14 April 2016

Practical implications of choice of test in National Institute for Health and Clinical Excellence (NICE) guidance for the prevention of Type 2 diabetes

scientific article published in January 2013

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy.

scientific article published on 31 January 2018

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

scientific article published on 19 June 2020

Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study

scientific article published on 15 December 2020

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia

scientific article

Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.

scientific article

Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.

scientific article published on 6 April 2010

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?

scientific article

Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes

scientific article published on 18 July 2005

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

scientific article published on 13 November 2016

The challenge of diagnosing type 1 diabetes in older adults

scientific article published on 11 February 2020

The clinical utility of C‐peptide measurement in the care of patients with diabetes ⬇️

scientific article published on July 1, 2013

The impact of gender on urine C-peptide creatinine ratio interpretation

scientific article published on 08 May 2012

The impact of insulin administration during the mixed meal tolerance test

scientific article published in October 2012

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

scientific article published on January 2014

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017

article

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

scientific article published on 04 April 2019

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or

scientific article published on 21 December 2020

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

scientific article published on 10 April 2019

Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review

article

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

scientific article

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes ⬇️

scientific article

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.

scientific article published in September 2011

Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study

scientific article published on 18 March 2019

List of works by Angus G Jones

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin

Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studies

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature

Comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials"

Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive.

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data

Effect of the Holiday Season in Patients With Diabetes: Glycemia and Lipids Increase Postholiday, but the Effect Is Small and Transient

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.

Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes

Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

Practical implications of choice of test in National Institute for Health and Clinical Excellence (NICE) guidance for the prevention of Type 2 diabetes

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy.

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia

Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.

Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?

Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

The challenge of diagnosing type 1 diabetes in older adults

The clinical utility of C‐peptide measurement in the care of patients with diabetes ⬇️

The impact of gender on urine C-peptide creatinine ratio interpretation

The impact of insulin administration during the mixed meal tolerance test

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes ⬇️

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.

Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study